Results 41 to 50 of about 7,594,057 (369)

STE029 Overcomes EGFR-TKI Resistance in Human Lung Adenocarcinoma

open access: yesChinese Journal of Lung Cancer, 2022
Background and objective Acquired and primary resistance to epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) is still the bottleneck of clinical treatment of advanced non-small cell lung cancer (NSCLC).
Lin HUANG   +5 more
doaj   +1 more source

Transthyretin Stimulates Tumor Growth through Regulation of Tumor, Immune, and Endothelial Cells [PDF]

open access: yes, 2019
Early detection of lung cancer offers an important opportunity to decrease mortality while it is still treatable and curable. Thirteen secretory proteins that are Stat3 downstream gene products were identified as a panel of biomarkers for lung cancer ...
Ding, Xinchun   +6 more
core   +1 more source

Lung Cancer in Belgium [PDF]

open access: yesJournal of Thoracic Oncology, 2021
Introduction: Health Care System - The kingdom of Belgium with its capital Brussels is located in Western Europe (Fig. 1) and has a population of 11,492,641 inhabitants (January 2020) for a surface of 30,689 km2. The country is a member of the European Union (EU) and federally organized with a Dutch-speaking majority in the northern Flemish region, a ...
Ocak, Sebahat   +13 more
openaire   +6 more sources

Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution.

open access: yesJournal of the American Medical Association (JAMA), 2002
CONTEXT Associations have been found between day-to-day particulate air pollution and increased risk of various adverse health outcomes, including cardiopulmonary mortality.
A. Pope   +6 more
semanticscholar   +1 more source

Non‐small cell lung cancer in China

open access: yesCancer Communications, 2022
In China, lung cancer is a primary cancer type with high incidence and mortality. Risk factors for lung cancer include tobacco use, family history, radiation exposure, and the presence of chronic lung diseases. Most early‐stage non‐small cell lung cancer
Peixin Chen   +3 more
semanticscholar   +1 more source

Economic Burden for Lung Cancer Survivors in Urban China. [PDF]

open access: yes, 2017
BackgroundWith the rapid increase in the incidence and mortality of lung cancer, a growing number of lung cancer patients and their families are faced with a tremendous economic burden because of the high cost of treatment in China.
Du, Jian   +10 more
core   +2 more sources

Identification of a novel oxidative stress-related prognostic model in lung adenocarcinoma

open access: yesFrontiers in Pharmacology, 2022
Background: Oxidative stress (OxS) participates in a variety of biological processes, and is considered to be related to the occurrence and progression of many tumors; however, the potential diagnostic value of OxS in lung cancer remains unclear.Methods:
Yifan Zhu   +15 more
doaj   +1 more source

Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring

open access: yesMolecular Cancer, 2022
Primary lung cancer is one of the most common malignant tumors in China. Approximately 60% of lung cancer patients have distant metastasis at the initial diagnosis, so it is necessary to find new tumor markers for early diagnosis and individualized ...
Wen Li   +18 more
semanticscholar   +1 more source

A retrospective stenting study on superior vena cava syndrome caused by lung cancer

open access: yesThoracic Cancer, 2020
Background Superior vena cava syndrome (SVCS) is a common condition predominantly caused by lung cancer. The presence of symptoms of SVCS, such as elevated intracranial pressure and laryngeal edema, indicates an unfavorable prognosis for lung cancer ...
Sen Wei   +8 more
doaj   +1 more source

First‐Line Atezolizumab plus Chemotherapy in Extensive‐Stage Small‐Cell Lung Cancer

open access: yesNew England Journal of Medicine, 2018
BACKGROUND Enhancing tumor‐specific T‐cell immunity by inhibiting programmed death ligand 1 (PD‐L1)–programmed death 1 (PD‐1) signaling has shown promise in the treatment of extensive‐stage small‐cell lung cancer.
L. Horn   +20 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy